MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/irv.13234

Медицинская библиотека · Influenza and other respiratory viruses · 2023

Seroprevalence of SARS-CoV-2 infection in the general population of Nepal during the first and second generalized waves of the COVID-19 pandemic-2020-2021.

Paudel Krishna Prasad, Samuel Reuben, Jha Runa, Pandey Basu Dev, Edirisuriya Chathura, Shrestha Nebin Lal, Gyawali Pradip, Pokhrel Amrit, Shrestha Lilee, Mahato Ram Kumar, Hossain Shaikh Shah, Arunkumar Govindakarnavar, Bose Anindya Sekhar, Dhimal Meghnath, Gautam Dipendra, Neupane Subash, Thakur Nishant, Shrestha Saugat, Bhusal Nirajan, Jha Priya, Gupta Binod Prasad, Rayamajhi Rajan Bikram, Subedi Koshal Chandra, Kandel Shashi, Poudel Mukesh, Thapa Lila Bikram, Sharma Guna Nidhi, Gocotano Allison Eugenio, Sunny Avinash K, Gautam Rabin, Bhatta Deepak Raj, Awale Bal Krishna, Roka Bhola, Ojha Hemant Chandra, Baral Phanindra, Adhikari Mahendra Dhose, Lohani Guna Raj, Shrestha Mahendra, Singh Dipendra Raman, Aryal Laxman, Pandav Rajesh Sambhajirao, Pokhrel Roshan

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Few seroprevalence studies have been conducted on coronavirus disease (COVID-19) in Nepal. Here, we aimed to estimate seroprevalence and assess risk factors for infection in the general population of Nepal by conducting two rounds of sampling. The first round was in October 2020, at the peak of the first generalized wave of COVID-19, and the second round in July-August 2021, following the peak of the wave caused by the delta variant of SARS-CoV-2. We used cross-sectional probability-to-size (PPS)-based multistage cluster sampling to estimate the seroprevalence in the general population of Nepal at the national and provincial levels. We tested for anti-SARS-CoV-2 total antibody using the WANTAI SARS-CoV-2 Ab ELISA kit. In Round 1, the overall national seroprevalence was 14.4%, with provincial estimates ranging from 5.3% in Sudurpaschim to 27.3% in Madhesh Province. In Round 2, the estimated national seroprevalence was 70.7%, with the highest in the Madhesh Province (84.8%) and the lowest in the Gandaki Province (62.9%). Seroprevalence was comparable between males and females (Round 1, 15.8% vs. 12.2% and Round 2, 72.3% vs. 68.7%). The seroprevalence in the ecozones-Terai, hills, and mountains-was 76.3%, 65.3%, and 60.5% in Round 2 and 17.7%, 11.7%, and 4.6% in Round 1, respectively. In Nepal, COVID-19 vaccination was introduced in January 2021. At the peak of the first generalized wave of COVID-19, most of the population of Nepal remained unexposed to SARS-CoV-2. Towards the end of the second generalized wave in April 2021, two thirds of the population was exposed.

Для цитирования: Paudel Krishna Prasad, Samuel Reuben, Jha Runa, Pandey Basu Dev, Edirisuriya Chathura, Shrestha Nebin Lal, Gyawali Pradip, Pokhrel Amrit, Shrestha Lilee, Mahato Ram Kumar, Hossain Shaikh Shah, Arunkumar Govindakarnavar, Bose Anindya Sekhar, Dhimal Meghnath, Gautam Dipendra, Neupane Subash, Thakur Nishant, Shrestha Saugat, Bhusal Nirajan, Jha Priya, Gupta Binod Prasad, Rayamajhi Rajan Bikram, Subedi Koshal Chandra, Kandel Shashi, Poudel Mukesh, Thapa Lila Bikram, Sharma Guna Nidhi, Gocotano Allison Eugenio, Sunny Avinash K, Gautam Rabin, Bhatta Deepak Raj, Awale Bal Krishna, Roka Bhola, Ojha Hemant Chandra, Baral Phanindra, Adhikari Mahendra Dhose, Lohani Guna Raj, Shrestha Mahendra, Singh Dipendra Raman, Aryal Laxman, Pandav Rajesh Sambhajirao, Pokhrel Roshan. Seroprevalence of SARS-CoV-2 infection in the general population of Nepal during the first and second generalized waves of the COVID-19 pandemic-2020-2021.. Influenza and other respiratory viruses. 2023. DOI: 10.1111/irv.13234.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.